(Q54648453)

2 June 2018

title

Human mesenchymal stem cells towards non-alcoholic steatohepatitis in an immunodeficient mouse model. (English)

1 reference

2 June 2018

non-alcoholic steatohepatitis

main subject

steatohepatitis

0 references

1 reference

3

1 reference

2 June 2018

Ralf Weiskirchen

6

1 reference

2 June 2018

Bruno Christ

7

1 reference

2 June 2018

author name string

Sandra Winkler

1

1 reference

2 June 2018

Erawan Borkham-Kamphorst

2

1 reference

2 June 2018

Sandra Brückner

4

1 reference

2 June 2018

Matthias Dollinger

5

1 reference

2 June 2018

language of work or name

English

0 references

publication date

28 April 2014

1 reference

2 June 2018

Experimental Cell Research

published in

1 reference

2 June 2018

volume

326

1 reference

2 June 2018

issue

2

1 reference

2 June 2018

page(s)

230-239

1 reference

2 June 2018

Non-alcoholic fatty liver disease: the mist gradually clears

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.04.017

Non-alcoholic steatohepatitis: definitions and pathogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.04.017

Nonalcoholic steatohepatitis: the therapeutic challenge of a global epidemic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.04.017

How big a problem is non-alcoholic fatty liver disease?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.04.017

Hepatic stem/progenitor cells and stem-cell transplantation for the treatment of liver disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.04.017

Stem cell therapy in chronic liver disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.04.017

Current status of hepatocyte transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.04.017

Adipose tissue-derived mesenchymal stem cells as a source of human hepatocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.04.017

Stem cells for hepatic regeneration: the role of adipose tissue derived mesenchymal stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.04.017

Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.04.017

Mesenchymal stem cells: revisiting history, concepts, and assays.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.04.017

Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.04.017

Immune Regulation by Mesenchymal Stem Cells Derived from Adult Spleen and Thymus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.04.017

Treatment of inflammatory diseases with mesenchymal stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.04.017

A methionine-choline-deficient diet elicits NASH in the immunodeficient mouse featuring a model for hepatic cell transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.04.017

Protective effects of lipocalin-2 (LCN2) in acute liver injury suggest a novel function in liver homeostasis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.04.017

Induction of lipocalin-2 expression in acute and chronic experimental liver injury moderated by pro-inflammatory cytokines interleukin-1β through nuclear factor-κB activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.04.017

Functional integration of hepatocytes derived from human mesenchymal stem cells into mouse livers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.04.017

Hepatic transplantation of mesenchymal stem cells in rodent animal models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.04.017

The generation of hepatocytes from mesenchymal stem cells and engraftment into murine liver

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.04.017

Effects of bezafibrate, PPAR pan-agonist, and GW501516, PPARdelta agonist, on development of steatohepatitis in mice fed a methionine- and choline-deficient diet

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.04.017

New approaches to target microsomal triglyceride transfer protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.04.017

NASH is an Inflammatory Disorder: Pathogenic, Prognostic and Therapeutic Implications.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.04.017

Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.04.017

Liver fibrogenesis in non-alcoholic steatohepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.04.017

Principles of interleukin (IL)-6-type cytokine signalling and its regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.04.017

Human liver stem cells improve liver injury in a model of fulminant liver failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.04.017

Immediate intraportal transplantation of human bone marrow mesenchymal stem cells prevents death from fulminant hepatic failure in pigs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.04.017

Therapeutic potential of transplanted placental mesenchymal stem cells in treating Chinese miniature pigs with acute liver failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.04.017

Mesenchymal stem cell infusion therapy in a carbon tetrachloride-induced liver fibrosis model affects matrix metalloproteinase expression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.04.017

Adipose-derived stem cells can abrogate chemical-induced liver fibrosis and facilitate recovery of liver function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.04.017

Human umbilical cord mesenchymal stem cells improve liver function and ascites in decompensated liver cirrhosis patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.04.017

Improvement of liver function in liver cirrhosis patients after autologous mesenchymal stem cell injection: a phase I-II clinical trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.04.017

Non-alcoholic steatohepatitis: a microbiota-driven disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.04.017

Obesity and fatty liver are 'grease' for the machinery of hepatic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.04.017

Immunological mechanisms in the pathophysiology of non-alcoholic steatohepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.04.017

Innate immune receptors: key regulators of metabolic disease progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.04.017

Cytokines and the hepatic acute-phase response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.04.017

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.04.017

From chronic overfeeding to hepatic injury: role of endoplasmic reticulum stress and inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.04.017

Hepatic fibrosis -- overview

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.04.017

Pathogen- or damage-associated molecular patterns during nonalcoholic fatty liver disease development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.04.017

Nuclear factor high-mobility group box1 mediating the activation of Toll-like receptor 4 signaling in hepatocytes in the early stage of nonalcoholic fatty liver disease in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.04.017

Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.04.017

Interferon-gamma does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.04.017

Allogeneic mesenchymal stem cell and mesenchymal stem cell-differentiated chondrocyte suppress the responses of type II collagen-reactive T cells in rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.04.017

Prevention of allogeneic fetal rejection by tryptophan catabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.04.017

Human mesenchymal stem cells modulate allogeneic immune cell responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.04.017

Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.04.017

Immunobiology of human mesenchymal stem cells and future use in hematopoietic stem cell transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.04.017

Adipose tissue-derived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of the graft-versus-host disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.04.017

Immunosuppressive effects of mesenchymal stem cells: involvement of HLA-G

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.04.017

Role of mesenchymal stromal cells in solid organ transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.04.017

Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.04.017

Regenerative and immunomodulatory potential of mesenchymal stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.04.017

Immunomodulation by multipotent mesenchymal stromal cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.04.017

Mesenchymal stem cell-derived hepatocytes for functional liver replacement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.04.017

Bone marrow-derived cells express matrix metalloproteinases and contribute to regression of liver fibrosis in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.04.017

Immunomodulation of activated hepatic stellate cells by mesenchymal stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.04.017

Hepatic stellate cell-derived delta-like homolog 1 (DLK1) protein in liver regeneration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.04.017

Transforming growth factor-α attenuates hepatic fibrosis: possible involvement of matrix metalloproteinase-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.04.017

Role of platelets in chronic liver disease and acute liver injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.04.017

Epidermal growth factor (EGF) treatment on multipotential stromal cells (MSCs). Possible enhancement of therapeutic potential of MSC.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.04.017

Intravenous administration of multipotent stromal cells prevents the onset of non-alcoholic steatohepatitis in obese mice with metabolic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.04.017

Propranolol impairs liver regeneration after partial hepatectomy in C57Bl/6-mice by transient attenuation of hepatic lipid accumulation and increased apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.04.017

Mouse models in non-alcoholic fatty liver disease and steatohepatitis research.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.04.017

New concepts in liver regeneration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.04.017

Mesenchymal stem cells for the treatment of heart failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.04.017

Mesenchymal stem cell-derived molecules directly modulate hepatocellular death and regeneration in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.04.017

Mesenchymal stem cells as therapeutics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.04.017

IFATS collection: in vivo therapeutic potential of human adipose tissue mesenchymal stem cells after transplantation into mice with liver injury.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.04.017

10.1016/J.YEXCR.2014.04.017

7 January 2021

Identifiers

DOI

1 reference

2 June 2018

1 reference

2 June 2018